ERBB2 and cancer: Zuo et al previously demonstrated that ∼80% of normal breast samples expressed FOXP3 in the epithelial cell nuclei, whereas only 20% of cancer tissues expressed nuclear FOXP3 (i.e., mostly the HER2− or ER+ phenotype) (16), which is consistent with our findings (Tables II and III).